{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:56:46Z","timestamp":1794023806276,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.tvjl.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T13:38:00Z","timestamp":1520516280000},"page":"22-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors"],"prefix":"10.1016","volume":"235","author":[{"given":"J.L.","family":"Ireland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2018.03.002_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0021-9975(08)80260-5","article-title":"Equine pituitary adenoma: a functional and morphological study","volume":"109","author":"Boujon","year":"1993","journal-title":"Journal of Comparative Pathology"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2460\/javma.2003.223.93","article-title":"Demographic and clinical characteristics of geriatric horses: 467 Cases (1989-1999)","volume":"223","author":"Brosnahan","year":"2003","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2460\/javma.2003.223.99","article-title":"Assessment of clinical characteristics, management practices, and activities of geriatric horses","volume":"223","author":"Brosnahan","year":"2003","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0020","series-title":"Proceedings of the 40th Congress of the British Equine Veterinary Association","article-title":"A pilot study of the prevalence of disease within a geriatric horse population","author":"Chandler","year":"2001"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0025","first-page":"24","article-title":"Prevalence of equine Cushing\u2019s syndrome among older horses in Southern Vestsj\u00e6lland, Denmark","volume":"92","author":"Christiansen","year":"2009","journal-title":"Dansk Veterin\u00e6rtidsskrift"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0030","series-title":"Proceedings of the 9th International Congress of World Equine Veterinary Association","first-page":"391","article-title":"Panorama of equine geriatrics","author":"Codron","year":"2006"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1939-1676.1996.tb02016.x","article-title":"Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism","volume":"10","author":"Cou\u00ebtil","year":"1996","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0040","first-page":"742","article-title":"Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing\u2019s disease)","volume":"16","author":"Donaldson","year":"2002","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0045","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2460\/javma.2004.224.1123","article-title":"Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis","volume":"224","author":"Donaldson","year":"2004","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0050","series-title":"Proceedings of the 18th Annual Convention of the American Association of Equine Practitioners","article-title":"The recognition and diagnosis of a pituitary tumor in the horse","author":"Evans","year":"1972"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0055","first-page":"49","article-title":"Clinical signs and diagnosis of pituitary gland tumors in horses","volume":"142","author":"Feige","year":"2000","journal-title":"Schweizer Archiv f\u00fcr Tierheilkunde"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0060","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1939-1676.2006.tb01816.x","article-title":"Evaluation of the combined dexamethasone suppression\/thyrotropin-releasing hormone stimulation test for detection of pars intermedia pituitary adenomas in horses","volume":"20","author":"Frank","year":"2006","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0065","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3138\/jvme.1111.109R","article-title":"Searching the veterinary literature: a comparison of the coverage of veterinary journals by nine bibliographic databases","volume":"39","author":"Grindlay","year":"2012","journal-title":"Journal of Veterinary Medical Education"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/030098589902700606","article-title":"Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses","volume":"27","author":"Heinrichs","year":"1990","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.2042-3292.1992.tb01595.x","article-title":"Diagnosis of hyperadrenocorticism in the horse","volume":"4","author":"Hillyer","year":"1992","journal-title":"Equine Veterinary Education"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0080","first-page":"8","article-title":"The geriatric horse","volume":"17","author":"Hintz","year":"1995","journal-title":"Equine Practice"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.2042-3306.2010.00145.x","article-title":"A cross-sectional study of geriatric horses in the United Kingdom Part 1: demographics and management practices","volume":"43","author":"Ireland","year":"2011","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.2042-3306.2010.00142.x","article-title":"Cross-sectional study of geriatric horses in the United Kingdom Part 2: health care and disease","volume":"43","author":"Ireland","year":"2011","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tvjl.2011.03.021","article-title":"A survey of health care and disease in geriatric horses aged 30 years or older","volume":"192","author":"Ireland","year":"2012","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.2042-3306.2010.00361.x","article-title":"Disease prevalence in geriatric horses in the United Kingdom: veterinary clinical assessment of 200 cases","volume":"44","author":"Ireland","year":"2012","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.2042-3306.2010.00361.x","article-title":"Prevalence of clinical signs associated with endocrinopathies and laminitis in geriatric horses in the United Kingdom","volume":"44","author":"Ireland","year":"2012","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.rvsc.2013.05.007","article-title":"Preventive health care and owner-reported disease prevalence of horses and ponies in Great Britain","volume":"95","author":"Ireland","year":"2013","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.12681\/jhvms.15149","article-title":"Equine hyperadrenocorticism: a report of 4 natural cases","volume":"55","author":"Koutinas","year":"2004","journal-title":"Journal of the Hellenic Veterinary Medical Society"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0125","first-page":"533","article-title":"Equine Cushing\u2019s disease","volume":"18","author":"McCue","year":"2002","journal-title":"Veterinary Clinics of North America: Equine Practice"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2826.2005.01277.x","article-title":"Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction","volume":"17","author":"McFarlane","year":"2005","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arr.2007.02.001","article-title":"Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease","volume":"6","author":"McFarlane","year":"2007","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0140","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2746\/042516403776014271","article-title":"Efficacy of trilostane for the treatment of equine Cushing\u2019s syndrome","volume":"35","author":"McGowan","year":"2003","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0145","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1751-0813.2010.00638.x","article-title":"A survey of aged horses in Queensland, Australia. Part 2: clinical signs and owners\u2019 perceptions of health and welfare","volume":"88","author":"McGowan","year":"2010","journal-title":"Australian Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.2042-3306.2012.00578.x","article-title":"Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses","volume":"45","author":"McGowan","year":"2013","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.2042-3306.2012.00575.x","article-title":"Evaluation of basal plasma \u03b1-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses","volume":"45","author":"McGowan","year":"2013","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/vr.149.14.417","article-title":"Sentinel practice-based survey of the management and health of horses in northern Britain","volume":"149","author":"Mellor","year":"2001","journal-title":"Veterinary Record"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/0300985815608674","article-title":"What\u2019s new in old horses? Postmortem diagnoses in mature and aged equids","volume":"53","author":"Miller","year":"2016","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0175","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0180","series-title":"Proceedings of the 13th International Congress of World Equine Veterinary Association","article-title":"Prevalence and early clinical signs of equine pituitary pars intermedia dysfunction in horses older than 10 years in France","author":"Nolf","year":"2013"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0185","first-page":"391","article-title":"Demographics of health and disease in the geriatric horse","volume":"18","author":"Paradis","year":"2002","journal-title":"Veterinary Clinics of North America: Equine Practice"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0190","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2746\/042516402776250333","article-title":"Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing\u2019s disease with cyproheptadine or pergolide","volume":"34","author":"Perkins","year":"2002","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0195","doi-asserted-by":"crossref","first-page":"598","DOI":"10.21836\/PEM20100416","article-title":"Equine Cushing\u2019s Syndrome: long-term effect of pergolide therapy","volume":"26","author":"Pongratz","year":"2010","journal-title":"Pferdeheilkunde"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0200","series-title":"Proceedings of the Annual Convention of the American Association of Equine Practitioners","first-page":"22","article-title":"The Michigan Cushing\u2019s Project","author":"Schott","year":"2001"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0205","first-page":"237","article-title":"Pituitary pars intermedia dysfunction: Equine Cushing\u2019s disease","volume":"18","author":"Schott","year":"2002","journal-title":"Veterinary Clinics of North America: Equine Practice"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1751-0813.2012.00997.x","article-title":"Case series of equine pituitary pars intermedia dysfunction in a tropical climate","volume":"90","author":"Spelta","year":"2012","journal-title":"Australian Veterinary Journal"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0215","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0220","first-page":"594","article-title":"Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992)","volume":"133","author":"van der Kolk","year":"1993","journal-title":"Veterinary Record"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0225","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.2042-3292.1997.tb01308.x","article-title":"Equine Cushing\u2019s disease","volume":"9","author":"Van der Kolk","year":"1997","journal-title":"Equine Veterinary Education"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prevetmed.2016.07.011","article-title":"Prevalence, survival analysis and multimorbidity of chronic diseases in the general veterinarian-attended horse population of the UK","volume":"131","author":"Welsh","year":"2016","journal-title":"Preventive Veterinary Medicine"},{"key":"10.1016\/j.tvjl.2018.03.002_bib0235","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/endo-110-3-941","article-title":"Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing\u2019s horses","volume":"110","author":"Wilson","year":"1982","journal-title":"Endocrinology"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023318300649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023318300649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T17:56:48Z","timestamp":1719856608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023318300649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":47,"alternative-id":["S1090023318300649"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2018.03.002","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}